Althabe, F., Belizán, J. M., McClure, E. M., Hemingway-Foday, J., Berrueta, M., Mazzoni, A., Ciganda, A., Goudar, S. S., Kodkany, B. S., Mahantshetti, N. S., Dhaded, S. M., Katageri, G. M., Metgud, M. C., Joshi, A. M., Bellad, M. B., Honnungar, N. V., Derman, R. J., Saleem, S., Pasha, O., Ali, S., Hasnain, F., Goldenberg, R. L., Esamai, F., Nyongesa, P., Ayunga, S., Liechty, E. A., Garces, A. L., Figueroa, L., Hambidge, K. M., Krebs, N. F., Patel, A., Bhandarkar, A., Waikar, M., Hibberd, P. L., Chomba, E., Carlo, W. A., Mwiche, A., Chiwila, M., Manasyan, A., Pineda, S., Meleth, S., Thorsten, V., Stolka, K., Wallace, D. D., Koso-Thomas, M., Jobe, A. H., & Buekens, P. M. (2015). a population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet, 385(9968), 629–639. http://access.bl.uk/ark:/81055/vdc_100042385218.0x000037